Sign inJoin waitlistJoin the waitlist

Edward James

Physician · Advocate Lutheran General Hospital

Credentials: · · · ·

History

Advocate Lutheran General Hospital
Present

Medical Oncology
2005–2007
Internal Medicine
2002–2005
Doctor of Medicine
1998–2002

Research

Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer
British Journal of Cancer · 2016 · 174 citations
CD4 + primary cutaneous small/medium-sized pleomorphic T-cell lymphoma: a retrospective case series and review of literature
Review · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · First of 8 authors · 43 citations
Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature
Case report · Anti-Cancer Drugs · 2009 · First of 3 authors · 34 citations

BC
Bryan Chang
3 papers
Jill Lacy
2 papers
JS
Joseph Sokhn
2 papers
Stacey Stein
2 papers
AB
Anne Boustani
1 paper · 1 as a resident
Brandon Mancini
1 paper
Charles Cha
1 paper
Charles Rutter
1 paper
Edward Nabrinsky
1 paper · 1 as a resident
Francine Foss
1 paper
Howard Hochster
1 paper
Jeremy Kortmansky
1 paper

Clinical trials

Evaluation of Low-dose Irinotecan and Cyberknife® SBRT to Treat Colorectal Cancer With Limited Liver Metastasis
Study chair · Withdrawn
Wake Forest University Health Sciences
2013–2017
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Site PI · Recruiting · Phase 2, Phase 3
National Cancer Institute (NCI)
2024–2027
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2028